Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cynthia Larmore"'
Autor:
Talia M. Muram, Steven R. Feldman, Vanita Tongbram, Charles Bay, Mwangi J Murage, Andre B. Araujo, Russel Burge, Cynthia Larmore, William N Malatestinic, Sarah Clifford, Nicole Johnson
Publikováno v:
Patient preference and adherence
Purpose Proper adherence and persistence to medications are crucial for better quality of life and improved outcomes in rheumatoid arthritis (RA), psoriasis (PsO), and psoriatic arthritis (PsA). We systematically describe current adherence and persis
Autor:
Andre B. Araujo, Sze-jung Wu, Kalyani Sonawane, Lawrence Chang, Joseph Singer, Natalie N. Boytsov, Ralph Quimbo, John T. Hinton, Cynthia Larmore, David M. Kern
Publikováno v:
Rheumatology and Therapy
Introduction To describe treatment patterns in newly diagnosed rheumatoid arthritis (RA) patients in a large, nationally representative managed-care database. Methods Newly diagnosed RA patients were identified from 07/01/2006–08/31/2014. Patients
Autor:
Carol L. Gaich, Bob Salim, Andre B. Araujo, Xiang Zhang, Leslie R. Harrold, Sabrina Rebello, George W. Reed, Natalie N. Boytsov, Cynthia Larmore
Publikováno v:
Rheumatology and Therapy. 5:215-229
Implementation of a treat-to-target strategy is challenging when the patient and physician prioritize different goals. This study aimed to “translate” improvements in Clinical Disease Activity Index (CDAI) to concepts that resonate with patients
Autor:
Natalie N. Boytsov, Cynthia Larmore, Leslie R. Harrold, Andre B. Araujo, Carol L. Gaich, Sabrina Rebello, Marc A Mason, Xiang Zhang
Publikováno v:
Current Medical Research and Opinion. 32:1959-1967
Determine healthcare resource utilization (HCRU) in biologic-naïve initiators of TNF inhibitors (TNFis) associated with their disease activity from a national cohort of rheumatoid arthritis (RA) patients.RA patients were identified at their first TN
Autor:
Won Chan Lee, Hsiao D. Lieu, Mark B. Effron, Jingsong Lu, Yajun Zhu, Mitch DeKoven, Swapna Karkare, Cynthia Larmore, Cliff Molife, George W. Vetrovec
Publikováno v:
Catheterization and Cardiovascular Interventions. 88:535-544
Objectives: The 30-day clinical outcomes with prasugrel or ticagrelor were comparedusing a US payer database in patients with acute coronary syndrome (ACS) undergoingpercutaneous coronary intervention (PCI).Background: Prasugrel and ticagrelor dem-on
Autor:
Elizabeth Marrett, Feride Frech-Tamas, Cliff Molife, Jingsong Lu, Swapna Karkare, Patrick L. McCollam, Cynthia Larmore, George W. Vetrovec, Mark B. Effron, Mitch DeKoven, Yajun Zhu
Publikováno v:
Journal of Medical Economics. 18:898-908
Objective:To compare healthcare resource utilization (HCRU) and healthcare costs in patients with acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI) and treated with prasugrel or ticagrelor.Methods:Hospital charge mas
Autor:
Natalie N. Boytsov, KR Saverno, M Datar, Cynthia Larmore, PL Abbott, R Bhattacharya, R Nair, L Dixon, Xiang Zhang, Carol L. Gaich
Publikováno v:
Value in Health. 21:S201-S202
Autor:
George W Vetrovec, Cynthia Larmore, Cliff Molife, Mitch DeKoven, Swapna Karkare, Yajun E Zhu, Feride Frech-Tamas, Jingsong Lu, Won C Lee, Patrick Mc Collam, Elizabeth Marrett, Mark B Effron
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 7
Background: This retrospective, real-world claims data base study in patients (pts) with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) demonstrated that prasugrel (pras) was non-inferior to ticagrelor (ticag) for
Autor:
Cliff Molife, Feride Frech-Tamas, Mark B Effron, Mitch DeKoven, Swapna Karkare, Yajun E Zhu, Cynthia Larmore, Jingsong Lu, Won C Lee, Patrick Mc Collam, Elizabeth Marrett, George W Vetrovec
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 7
Objectives: To compare all-cause healthcare resource utilization and costs with prasugrel (pras) vs. ticagrelor (ticag) with real world data in patients (pts) with ACS managed with PCI. Methods: The IMS Patient-Centric Data Warehouse was used to iden
Autor:
Elizabeth Marrett, Mark B. Effron, Patrick Mc Collam, Cliff Molife, Swapna Karkare, Won Chan Lee, Jingsong Lu, Feride Frech-Tamas, Yajun Zhu, Mitch DeKoven, George W. Vetrovec, Cynthia Larmore
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 7
Objective: To show that prasugrel (pras) was non-inferior to ticagrelor (ticag) in terms of healthcare resource utilization (HCRU) based upon 30- and 90-day all-cause rehospitalization rates among patients (pts) with acute coronary syndrome (ACS) man